Status:
COMPLETED
Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Alzheimer's Disease
Healthy
Eligibility:
MALE
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the bioavailability of four experimental formulations relative to the current reference formulation used in the Phase 2 study.
Eligibility Criteria
Inclusion
- Young healthy male subjects
Exclusion
- Women
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00901498
Start Date
May 1 2009
End Date
July 1 2009
Last Update
January 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mds Pharma Services (Us) Inc.
Neptune City, New Jersey, United States, 07753